UNION OF INDIA vs M/S SWISS GARNIER LIFE SCIENCES .

The Supreme Court upheld the Delhi High Court's decision affirming the order that set aside price fixation notifications for 'Doxofylline formulations' under the Drugs (Prices Control) Order, 1995. The Court found that 'Doxofylline' does not qualify as a bulk drug as defined in the DPCO, 1995, thereby establishing that the government cannot impose price controls on it. The ruling reinforces the interpretation of bulk drugs under the DPCO, ensuring that only substances meeting specific criteria are subject to price regulation.